2022年度業績

英文論文
  1. Abe H, Kurose Y, Takahama S, Kume A, Nishida S, Fukasawa M, Yasunaga Y, Ushiku T, Ninomiya Y, Yoshizawa A, Murao K, Sato S, Kitsuregawa M, Harada T, Kitagawa M, Fukayama M, JP-AID/NII Study Group for Gastric Biopsy Pathology. Development and multi-institutional validation of an artificial intelligence-based diagnostic system for gastric biopsy. Cancer Science. 2022-10;113(10):3608-3617. doi:10.1111/cas.15514. PMID:36068652.
  2. Abe K, Anzai H, Eguchi S, Ikemura M, Shinozaki-Ushiku A, Shinagawa T, Sonoda H, Yoshioka Y, Nagai Y, Abe S, Matsuzaki H, Yokoyama Y, Emoto S, Murono K, Sasaki K, Nozawa H, Ushiku T, Ishihara S. Metastasis of Ovarian Cancer to the Descending Colon.Case Rep Gastroenterol. 2023-2;17(1):129-136. doi:10.1159/000529299. PMID:36865675.
  3. Adachi Y, Ueda K, Nomura S, Ito K, Katoh M, Katagiri M, Yamada S, Hashimoto M, Zhai B, Numata G, Otani A, Hinata M, Hiraike Y, Waki H, Takeda N, Morita H, Ushiku T, Yamauchi T, Takimoto E, Komuro I. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling. Nat Commun. 2022-9;13:5117. doi: 10.1038/s41467-022-32658-6. PMID:36071032.
  4. Amano Y, Kage H, Tanaka G, Sato Y, Tanaka M, Nagase T. Multiple Brain Metastases in a Patient with ROS1 Fusion-Positive Lung Adenocarcinoma as a Disease Flare due to Crizotinib Cessation Caused by Disseminated Aseptic Inflammation from Crizotinib-Associated Renal Cysts: A Case Report. Case Rep Oncol. 2022-5;15:338-344. doi:10.1159/000523737. eCollection 2022 Jan-Apr. PMID:35529295.
  5. Arai J, Aoki T, Hayakawa Y, Niikura R, Ishibashi R, Suzuki N, Tsuji Y, Yamada A, Ushiku T, Fujishiro M. Risk and preventive factors of early-onset colorectal neoplasms: endoscopic and histological database analysis. J Gastroenterol Hepatol. 2023-2;38(2):259-268. doi: 10.1111/jgh.16045. PMID:36302073.
  6. Arai J, Niikura R, Hayakawa Y, Suzuki N, Hirata Y, Ushiku T, Fujishiro M. Clinicopathological Features of Gastric Cancer with Autoimmune Gastritis. Biomedicines. 2022-4;10(4):884. doi: 10.3390/biomedicines10040884. PMID35453635.
  7. Fujimoto K, Gonoi W, Ishida M, Okimoto N, Nyunoya K, Abe H, Ushiku T, Abe O. Association between postmortem computed tomography value of cerebrospinal fluid and time after death: A longitudinal study of antemortem and postmortem computed tomography. J Forensic Leg Med. 2023-1;93:102461. doi: 10.1016/j.jflm.2022.102461. PMID:36470057.
  8. Fukagawa K, Takahashi Y, Yamamichi N, Kageyama-Yahara N, Sakaguchi Y, Obata M, Cho R, Sakuma N, Nagao S, Miura Y, Tamura N, Ohki D, Mizutani H, Yakabi S, Minatsuki C, Niimi K, Tsuji Y, Yamamichi M, Shigi N, Tomida S, Abe H, Ushiku T, Koike K, Fujishiro M. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type. Gastric Cancer. 2023-1;26(1):44-54. doi: 10.1007/s10120-022-01334-5. PMID:36094595.
  9. Fukushima H, Morita K, Ikemura M, Tanaka M, Nakai Y, Maki H, Suzuki T, Mizuno S, Nakai Y, Kurokawa M. Acute pancreatitis as the initial manifestation of acute myeloid leukemia with chromosome 16 rearrangements. Int J Hematol. 2023-3;Online ahead of print. doi:10.1007/s12185-023-03580-4. PMID:36964839.
  10. Furuya G, Katoh H, Atsumi S, Hashimoto I, Komura D, Hatanaka R, Senga S, Hayashi S, Akita S, Matsumura H, Miura A, Mita H, Nakakido M, Nagatoishi S, Sugiyama A, Suzuki R, Konishi H, Yamamoto A, Abe H, Hiraoka N, Aoki K, Kato Y, Seto Y, Yoshimura C, Miyadera K, Tsumoto K, Ushiku T, Ishikawa S. Nucleic Acid-triggered Tumoral Immunity Propagates pH-selective Therapeutic Antibodies through Tumor-driven Epitope Spreading. Cancer Sci. 2023-1;114(1):321-338. doi:10.1111/cas.15596. PMID:36136061.
  11. Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, Miyazato Y, Ishikane M, Kishino Y, Miyazaki H, Igari T, Katano H, Suzuki T, Murayama S, Arai N. An Autopsy Report of a Case with Cerebral Infarction Complicated by Coronavirus Disease 2019 Infection. Intern Med. 2022-11;61(22):3439-3444. doi:10.2169/internalmedicine.9726-22. PMID:36070957.
  12. Hakozaki Y, Yamada Y, Kawai T, Nakamura M, Takeshima Y, Iwaki T, Teshima T, Kinoshita Y, Fujii Y, Akiyama Y, Sato Y, Yamada D, Suzuki M, Kashiwagi-Hakozaki M, Ushiku T, Kume H. Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer. Sci Rep. 2022-9;12(1):16202. doi: 10.1038/s41598-022-20319-z. PMID:36171391.
  13. Hamada T, Oyama H, Nakai Y, Tange S, Arita J, Hakuta R, Ijichi H, Ishigaki K, Kanai S, Kawaguchi Y, Kogure H, Mizuno S, Saito K, Saito T, Sato T, Suzuki T, Takahara N, Tanaka M, Tateishi K, Ushiku T, Hasegawa K, Fujishiro M. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct. Clin Gastroenterol Hepatol. 2023-2;Online ahead of print. doi:10.1016/j.cgh.2023.01.032. PMID:36787835.
  14. Hirano Y, Shinya Y, Aono T, Hasegawa H, Kawashima M, Shin M, Takami H, Takayanagi S, Umekawa M, Ikemura M, Ushiku T, Taoka K, Tanaka S, Saito N. The Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in the Era of Molecular-Based Diagnosis and Treatment Decisions. Curr Oncol. 2022-6;29(7):4558-4565. doi:10.3390/curroncol29070360. PMID:35877220.
  15. Hirata Y, Iida S, Arashiro T, Nagasawa S, Saitoh H, Abe H, Ikemura M, Makino Y, Sawa R, Iwase H, Ushiku T, Suzuki T, Akitomi S. Impact of the COVID-19 pandemic on pathological autopsy practices in Japan. Pathol Int. 2023-3;73(3):120-126. doi:10.1111/pin.13306. PMID:36598024.
  16. Hongo H, Miyawaki S, Teranishi Y, Mitsui J, Katoh H, Komura D, Tsubota K, Matsukawa T, Watanabe M, Kurita M, Yoshimura J, Dofuku S, Ohara K, Ishigami D, Okano A, Kato M, Hakuno F, Takahashi A, Kunita A, Ishiura H, Shin M, Nakatomi H, Nagao T, Goto H, Takahashi SI, Ushiku T, Ishikawa S, Okazaki M, Morishita S, Tsuji S, Saito N. Somatic GJA4 gain-of-function mutation in orbital cavernous venous malformations. Angiogenesis. 2023-2;26(1):37-52. doi:10.1007/s10456-022-09846-5. PMID:35902510.
  17. Hoshi D, Kita E, Maru Y, Kogashi H, Nakamura Y, Tatsumi Y, Shimozato O, Nakamura K, Sudo K, Tsujimoto A, Yokoyama R, Kato A, Ushiku T, Fukayama M, Itami M, Yamaguchi T, Hippo Y. Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid. Cancer Sci. 2023-3;114(3):1165-1179. doi:10.1111/cas.15656. PMID:36382538.
  18. Ishide T, Nishi H, Miyano S, Hirakawa Y, Honda K, Abe H, Sato M, Nangaku M. Kidney Podocyte Zebra Bodies after Lung Transplantation for Lymphangioleiomyomatosis. Intern Med. 2022-9;Online ahead of print. doi:10.2169/internalmedicine.0882-22. PMID:36351586.
  19. Ishii T, Mimura I, Nagaoka K, Naito A, Sugasawa T, Kuroda R, Yamada D, Kanki Y, Kume H, Ushiku T, Kakimi K, Tanaka T, Nangaku M. Effect of M2-like macrophages of the injured-kidney cortex on kidney cancer progression. Cell Death Discovery 2022-12;8:480. doi: 10.1038/S41420-022-01255-3. PMID:36470862.
  20. Ishizaka A, Taguchi A, Tsuruga T, Maruyama M, Kawata A, Miyamoto Y, Tanikawa M, Ikemura M, Sone K, Mori M, Koga K, Ushiku T, Oda K, Osuga Y. Endometrial cancer with concomitant endometriosis is highly associated with ovarian endometrioid carcinoma: a retrospective cohort study. BMC Womens Health. 2022-8;22(1):332. doi: 10.1186/s12905-022-01917-5. PMID:35932070.
  21. Ito T, Kudoh S, Fujino K, Sanada M, Tenjin Y, Saito H, Nakaishi-Fukuchi Y, Kameyama H, Ichimura T, Udaka N, Kudo N, Matsuo A, Sato Y. Pulmonary neuroendocrine cells and small cell lung carcinoma: immunohistochemical study focusing on mechanisms of neuroendocrine differentiation. Acta Histochemica et Cytochemica. 2022-6;3:75–83. doi: 10.1267/ahc.22-00031. PMID:35821751.
  22. Iwatsuki-Horimoto K, Ueki H, Ito M, Nagasawa S, Hirata Y, Hashizume K, Ushiwata K, Iwase H, Makino Y, Ushiku T, Akitomi S, Imai M, Saitoh H, Kawaoka Y. SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters. mSphere. 2023-2;8(1):e0041122. doi:10.1128/msphere.00411-22. PMID:36625587.
  23. Kage H, Kohsaka S, Tatsuno K, Ueno T, Ikegami M, Zokumasu K, Shinozaki-Ushiku A, Nagai S, Aburatani H, Mano H, Oda K. Tumor mutational burden measurement using comprehensive genomic profiling assay. Jpn J Clin Oncol. 2022-8;52(8):917-921. doi: 10.1093/jjco/hyac063. PMID:35482395.
  24. Kakushima N, Hinata M, Ushiku T. White opaque substance in a non-neoplastic duodenal lesion. Dig Endosc. 2022-11;34(7):1495. doi:10.1111/den.14424. PMID:35997616.
  25. Kashima J, Hashimoto T, Yoshida A, Goto Y, Ushiku T, Ohe Y, Watanabe SI, Yatabe Y. Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma. Virchows Arch. 2022-12;481(6):893-901. doi:10.1007/s00428-022-03437-x. PMID:36305944.
  26. Kasuga S, Anzai H, Makise N, Sonoda H, Nagai Y, Abe S, Yokoyama Y, Ozawa T, Emoto S, Murono K, Sasaki K, Kawai K, Nozawa H, Ushiku T, Ishihara S. Giant filiform polyposis with high-grade dysplasia:A case report and review of the literature. Ann Med Surg (Lond). 2022-9;82:104433. doi: 10.1016/j.amsu.2022.104433. PMID:36268352.
  27. Kato H, Koga M, Kinoshita Y, Hidaka N, Hoshino Y, Takashi Y, Arai M, Kobayashi H, Katsura M, Nakamoto Y, Makise N, Ushiku T, Hoshi K, Nangaku M, Makita N, Fukumoto S, Ito N. Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors. J Endocr Soc. 2022-11;7(2):bvac181. doi:10.1210/jendso/bvac181. PMID:36540156.
  28. Kato H, Tateishi K, Fujiwara H, Nakatsuka T, Yamamoto K, Kudo Y, Hayakawa Y, Nakagawa H, Tanaka Y, Ijichi H, Otsuka M, Iwadate D, Oyama H, Kanai S, Noguchi K, Suzuki T, Sato T, Hakuta R, Ishigaki K, Saito K, Saito T, Takahara N, Kishikawa T, Hamada T, Takahashi R, Miyabayashi K, Mizuno S, Kogure H, Nakai Y, Hirata Y, Toyoda A, Ichikawa K, Qu W, Morishita S, Arita J, Tanaka M, Ushiku T, Hasegawa K, Fujishiro M, Koike K. MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages. Gastroenterology. 2022-4;162(4):1272-1287.e16. doi:10.1053/j.gastro.2021.12.254. PMID:34953915.
  29. Kawanishi A, Umekawa M, Miyawaki S, Fujitani S, Ishizawa T, Ushiku T, Hongo H, Teranishi Y, Shojima M, Shin M, Hasegawa K, Saito N. Long-term progression-free survival achieved in the skull base metastasis of gastrointestinal stromal tumor with introduction of tyrosine kinase inhibitor: illustrative case. J Neurosurg Case Lessons. 2022-4;3(16):CASE2257. doi:10.3171/CASE2257. PMID:36303489.
  30. Kawazoe Y, Shimamoto K, Yamaguchi R, Nakamura I, Yoneda K, Shinohara E, Shintani-Domoto Y, Ushiku T, Tsukamoto T, Ohe K. Computational Pipeline for Glomerular Segmentation and Association of the Quantified Regions with Prognosis of Kidney Function in IgA Nephropathy. Diagnostics (Basel). 2022-11;12(12):2955. doi:10.3390/diagnostics12122955. PMID:36552963.
  31. Kikuchi R, Emoto S, Nozawa H, Sasaki K, Murono K, Abe S, Sonoda H, Shinozaki-Ushiku A, Ishihara S. Jejunal intussusception and perforation due to enteric muco-submucosal elongated polyp: a case report and literature review. Surg Case Rep. 2023-1;9(1):4. doi: 10.1186/s40792-022-01584-6. PMID:36627469.
  32. Kishino Y, Matsukawa K, Matsumoto T, Miyazaki R, Wakabayashi T, Nonaka T, Kametani F, Hasegawa M, Hashimoto T, Iwatsubo T. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration. J Biol Chem. 2022-8;298(8):102191. doi: 10.1016/j.jbc.2022.102191. PMID:35753345.
  33. Ko T, Nomura S, Yamada S, Fujita K, Fujita T, Satoh M, Oka C, Katoh M, Ito M, Katagiri M, Sassa T, Zhang B, Hatsuse S, Yamada T, Harada M, Toko H, Amiya E, Hatano M, Kinoshita O, Nawata K, Abe H, Ushiku T, Ono M, Ikeuchi M, Morita H, Aburatani H, Komuro I. Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis. Nat Commun. 2022-6;13:3275. doi:10.1038/s41467-022-30630-y. PMID:35672400.
  34. Kobayashi H, Makise N, Shinozaki-Ushiku A, Zhang L, Ishibashi Y, Ikegami M, Tsuda Y, Kohsaka S, Ushiku T, Oda K, Miyagawa K, Aburatani H, Mano H, Tanaka S. Dramatic response to entrectinib in a patient with malignant peripheral nerve sheath tumor harboring novel SNRNP70-NTRK3 fusion gene. Genes Chromosomes Cancer. 2023-1;62(1):47-51. doi:10.1002/gcc.23089. PMID:35906852.
  35. Komura D, Onoyama T, Shinbo K, Odaka H, Hayakawa M, Ochi M, Herdiantoputri RR, Endo H, Katoh H, Ikeda T, Ushiku T, Ishikawa S. Restaining-based annotation for cancer histology segmentation to overcome annotation-related limitations among pathologists. Patterns (N Y). 2023-2;4(2):100688. doi: 10.1016/j.patter.2023.100688. PMID:36873900.
  36. Kondo A, Shinozaki-Ushiku A (co-first), Rokutan H, Kunita A, Ikemura M, Yamashita H, Seto Y, Nagae G, Tatsuno K, Aburatani H, Koinuma D, Ushiku T. Loss of Viral Genome with Altered Immune Microenvironment During Tumour Progression of Epstein-Barr Virus-Associated Gastric Carcinoma. J Pathol. 2023-2;Online ahead of print. doi: 10.1002/path.6067. PMID:36806225.
  37. Kume A, Shinozaki-Ushiku A (co-first), Kunita A, Kondo A, Ushiku T. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization. Am J Surg Pathol. 2022-10;46(10):1386-1396. doi:10.1097/PAS.0000000000001919. PMID:35605962.
  38. Kurihara M, Mano T, Eto F, Yao I, Sato K, Ohtomo G, Bannai T, Shibata S, Ishiura H, Ikemura M, Matsubara T, Morishima M, Saito Y, Murayama S, Toda T, Setou M, Iwata A. Proteomic profile of nuclei containing p62-positive inclusions in a patient with neuronal intranuclear inclusion disease. Neurobiol Dis. 2023-2;177:105989. doi:10.1016/j.nbd.2023.105989. PMID:36621630.
  39. Kuroe T, Watanabe R, Morisue R, Miyazaki S, Kojima M, Murata SC, Nakai T, Taki T, Sakashita S, Sakamoto N, Matsubara N, Masuda H, Ushiku T, Ishii G. Dirty necrosis in renal cell carcinoma is associated with NETosis and systemic inflammation. Cancer Med. 2023-2;12(4):4557-4567. doi:10.1002/cam4.5249. PMID:36127822.
  40. Kurokawa R, Kato S, Koyama H, Ishida M, Kurokawa M, Kuroda R, Ushiku T, Kume H, Abe O. Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer. European Journal of Radiology. 2022-12;157:110595. doi: 10.1016/j.ejrad.2022.110595. PMID.36356462.
  41. Kusakabe M, Taguchi A, Tanikawa M, Hoshi D, Tsuchimochi S, Qian X, Toyohara Y, Kawata A, Wagatsuma R, Yamaguchi K, Yamamoto Y, Ikemura M, Sone K, Mori-Uchino M, Matsunaga H, Tsuruga T, Nagamatsu T, Kukimoto I, Wada-Hiraike O, Kawazu M, Ushiku T, Takeyama H, Oda K, Kawana K, Hippo Y, Osuga Y. Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine. Cancer Med. 2023-1;Online ahead of print. doi:10.1002/cam4.5588. PMID:36691316.
  42. Kusakabe M, Taguchi A, Tanikawa M, Wagatsuma R, Yamazaki M, Tsuchimochi S, Toyohara Y, Kawata A, Baba S, Ueno T, Sone K, Mori-Uchino M, Ikemura M, Matsunaga H, Nagamatsu T, Wada-Hiraike O, Kawazu M, Ushiku T, Takeyama H, Oda K, Kawana K, Mano H, Osuga Y. Cells with stem-like properties are associated with the development of HPV18-positive cervical cancer. Cancer Sci. 2023-3;114(3):885-895. doi:10.1111/cas.15664. PMID:36404139.
  43. Liu B, Katoh H, Komura D, Yamamoto A, Ochi M, Onoyama T, Abe H, Ushiku T, Seto Y, Suo J, Ishikawa S. Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers. J Pathol. 2022-10;258(2):106-120. doi:10.1002/path.5980. PMID:35696251.
  44. Liu PY*, Fukuma N*, Hiroi Y*, Kunita A*, Tokiwa H*, Ueda K, Kariya T, Numata G, Adachi Y, Tajima M, Toyoda M, Li Y, Noma K, Harada M, Toko H, Ushiku T, Kanai Y, Takimoto E, Liao JK, Komuro I(*; equal contributor). Tie2-Cre–Induced Inactivation of Non-Nuclear Estrogen Receptor-α Signaling Abrogates Estrogen Protection Against Vascular Injury. JACC: Basic to Translational Science. 2022-11;8(1):55-67. doi:10.1016/j.jacbts.2022.07.001. PMID:36777173.
  45. Makise N, Shimoi T, Sunami K, Aoyagi Y, Kobayashi H, Tanaka S, Kawai A, Yonemori K, Ushiku T, Yoshida A. Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base. Histopathology. 2023-2;82(3):420-430. doi:10.1111/his.14823. PMID:36217885.
  46. Masuzawa H, Suzuki F, Amemiya S, Orimo K, Ishiura H, Hara R, Toda T, Nakazawa T, Honda A, Tanaka M, Hinata M, Abe O. A case of intravascular lymphoma presenting with a lesion in the splenium of the corpus callosum. Radiol Case Rep. 2023-3;18:1929-1932. doi: 10.1016/j.radcr.2023.02.025. PMID:36970234.
  47. Matsuhashi A, Tanaka S, Takami H, Nomura M, Ikemura M, Matsubayashi Y, Shinoda Y, Yamada K, Sakai Y, Karasawa Y, Takayanagi S, Saito N. Recurrent glioblasoma metastatic to the lumbar vertebra: A case report and literature review: Surgical oncology. Front Oncol. 2023-2;13:1101552. doi: 10.3389/fonc.2023.1101552. PMID:36874120.
  48. Matsumoto N, Kashio A, Yoshida M, Kondo K, Miyamoto S, Okazaki M, Ikemura M, Ushiku T, Yamasoba T. Cholesterol granuloma in facial nerve canal presenting with facial nerve paralysis. Auris Nasus Larynx. 2022-10;S0385-8146(22):00210-3. doi: 10.1016/j.anl.2022.09.007. PMID:36220679.
  49. Matsumoto Y, Kage H, Morota M, Zokumasu K, Ando T, Maemura K, Watanabe K, Kawakami M, Hinata M, Ushiku T, Nakajima J, Nagase T. Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer. Jpn J Clin Oncol. 2023-1;53(1):63-73. doi: 10.1093/jjco/hyac148. PMID:36151049.
  50. Mita H, Katoh H, Komura D, Kakiuchi M, Abe H, Rokutan H, Yagi K, Nomura S, Ushiku T, Seto Y, Ishikawa S. Aberrant Cadherin11 expression predicts distant metastasis of gastric cancer. Pathol Res Pract. 2023-2;242:154294. doi:10.1016/j.prp.2022.154294. PMID:36610328.
  51. Miyamoto K, Kobayashi H, Zhang L, Tsuda Y, Makise N, Yasunaga Y, Ikemura M, Nakai Y, Shibata E, Ushiku T, Tanaka S. Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential in the Posterior Mediastinum of a Young Patient with Neurofibromatosis Type 1: A Case Report. Case Rep Oncol. 2022-11;15(3);988-994. doi:10.1159/000526844. PMID:36636686.
  52. Miyashita H, Taoka K, Kume A, Ushiku A, Ushiku T, Toyama K, Kurokawa M. Clinical usefulness of a novel classification of T cell distribution patterns in the tumor microenvironment of follicular lymphoma to detect transformation. Ann Hematol. 2022-11;101(11):2477-2483. doi:10.1007/s00277-022-04947-z. PMID:36069932.
  53. Naito Y, Notohara K, Omori Y, Aishima S, Itoi T, Ohike N, Okabe Y, Kojima M, Tajiri T, Tanaka M, Tsuneki M, Nakagohri T, Norose T, Hirabayashi K, Fukumura Y, Mitsuhashi T, Yamaguchi H, Fukushima N, Furukawa T. Diagnostic Categories and Key Features for Pathological Diagnosis of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Samples of Pancreatic Lesions: A Consensus Study. Pancreas. 2022-10;51(9):1105-1111. doi:10.1097/MPA.0000000000002179. PMID:37078931.
  54. Nakagawa K, Sho M, Fujishiro M, Kakushima N, Horimatsu T, Okada KI, Iguchi M, Uraoka T, Kato M, Yamamoto Y, Aoyama T, Akahori T, Eguchi H, Kanaji S, Kanetaka K, Kuroda S, Nagakawa Y, Nunobe S, Higuchi R, Fujii T, Yamashita H, Yamada S, Narita Y, Honma Y, Muro K, Ushiku T, Ejima Y, Yamaue H, Kodera Y. Clinical practice guidelines for duodenal cancer 2021. J Gastroenterol. 2022-12;57(12):927-941. doi: 10.1007/s00535-022-01919-y. PMID:36260172.
  55. Nakagawa N, Kawakami M, Suzuki M, Noguchi S, Mitani A, Tanaka G, Shinozaki-Ushiku A, Nagase T. Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report. Respir Med Case Rep. 2023-3;43:101836. doi: 10.1016/j.rmcr.2023.101836. PMID:36950025.
  56. Nakamura M, Kanda S, Kajiho Y, Hinata M, Tomonaga K, Fujishiro J, Harita Y. A case of right hypodysplastic kidney and ectopic ureter associated with bicornuate uterus in a prepubertal girl. CEN Case Rep. 2023-2;12(1):122-129. doi:10.1007/s13730-022-00730-1. PMID:36056295.
  57. Nakazaki K, Yoshida M, Masamoto Y, Shinozaki-Ushiku A, Ikemura M, Hisamoto T, Yasunaga M, Sato S, Kurokawa M. Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis. Int J Hematol. 2022-9;116(3):446-452. doi:10.1186/s12920-022-01188-x. PMID:35255903.
  58. Nejo T, Takayanagi S, Tanaka S, Shinozaki-Ushiku A, Kohsaka S, Nagata K, Yokoyama M, Sora S, Ushiku T, Mukasa A, Aburatani H, Mano H, Saito N. Primary Intracranial Spindle Cell Sarcoma, DICER1-Mutant, with MDM2 Amplification Diagnosed on the Basis of Extensive Molecular Profiling. Clin Med Insights Case Rep. 2022-10;15:11795476221131189. doi:10.1177/11795476221131189. PMID:36277904.
  59. Obo T, Morita K, Sumida Y, Nakazaki-Watadani K, Ikemura M, Yasaka K, Abe O, Takami H, Takayanagi S, Tanaka S, Maki H, Masamoto Y, Miwa A, Kurokawa M. Isolated relapse of plasma cell leukemia in the central nervous systems: a case report and literature review. Int J Hematol. 2023-2;Online ahead of print. doi: 10.1007/s12185-023-03545-7. PMID:36735218.
  60. Ohki D, Tsuji Y, Kuroda R, Ushiku T, Fujishiro M. Gastrointestinal: A case of significant esophageal ulceration due to oral iron pill therapy. J Gastroenterol Hepatol. 2023-1;Online ahead of print. doi: 10.1111/jgh.16090. PMID:36658106.
  61. Ohki D, Tsuji Y, Tanaka M, Ushiku T, Fujishiro M. A case of a tiny neuroendocrine carcinoma in a large flat-elevated rectal tumor causing multiple liver metastases. Clin J Gastroenterol. 2022-12;15(6):1078-1082. doi:10.1007/s12328-022-01691-9. PMID:6044167.
  62. Oyama T, Taoka K, Chiba A, Masamoto Y, Ikemura M, Honda A, Maki H, Kurokawa M. Daratuumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deltion. Int J Hematol. 2023-3;117(3):463-467. doi: 10.1007/s12185-022-03459-w. PMID:36202948.
  63. Saito N, Sato Y, Abe H, Wada I, Kobayashi Y, Nagaoka K, Kushihara Y, Ushiku T, Seto Y, Kakimi K. Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer. Sci Rep. 2022-5;12:8576. doi:10.1038/s41598-022-12610-w. PMID:35595859.
  64. Sato D, Hasegawa H, Nishijima H, Kawase K, Okamoto K, Iwasaki A, Shinya Y, Abe M, Miyazaki Y, Saito N. Intracranial aspergilloma mimicking metachronous meningioma following transsphenoidal removal of a tuberculum sellae meningioma: illustrative case. Journal of Neurosurgery: Case Lessons. 2023-1;5(5):10.3171/CASE22519. PMID:36718867.
  65. Sato D, Takayanagi S, Takami H, Iwamoto T, Nomura M, Nambu S, Ikemura M, Tanaka S, Saito N. Novel case of primary intracranial solitary plasmacytoma presenting with significant intratumoral hemorrhage. Surg Neurol Int. 2022-4;13:157. doi:10.25259/SNI_66_2022. PMID:35509594.
  66. Sato M, Akamatsu M, Shima T, Ikegami T, Yanase M, Mikami S, Imamura J, Nakatsuka T, Tateishi R, Yamauchi N, Ushiku T, Okanoue T, Fujishiro M, Hida E, Koike K. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. Am J Gastroenterol. 2023-1;Online ahead of print. doi: 10.14309/ajg.0000000000002143. PMID:36656974.
  67. Shi C, Badgwell BD, Grabsch HI, Gibson MK, Hong SM, Kumarasinghe P, Lam AK, Lauwers G, O’Donovan M, van der Post RS, Tang L, Ushiku T, Vieth M, Selinger CI, Webster F, Nagtegaal ID. Data Set for Reporting Carcinoma of the Stomach in Gastrectomy. Arch Pathol Lab Med. 2022-9;146(9):1072-1083. doi: 10.5858/arpa.2021-0225-OA. PMID:34919649.
  68. Shiiya H, Sato M, Shinozaki-Ushiku A, Konoeda C, Kitano K, Nakajima J. Exacerbation of Secondary Pulmonary Hypertension by Flat Chest after Lung Transplantation. Ann Thorac Cardiovasc Surg. 2022-8;28(4):298-301. doi:10.5761/atcs.cr.20-00230. PMID:33148928.
  69. Shintani-Domoto Y, Sugiura Y, Ogawa M, Sugiyama E, Abe H, Sakatani T, Ohashi R, Ushiku T, Fukayama M. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study. PLoS One. 2022-10;17;e0275993. doi: 10.1371/journal.pone.0275993. PMID:36240260.
  70. Shinozaki-Ushiku A, Kunita A, Iwasaki A, Kato M, Yamazawa S, Abe H, Ushiku T. Microsatellite Instability Profiles of Gastrointestinal Cancers: Comparison between Non-Colorectal and Colorectal Origin. Histopathology. 2023-2;82(3):466-477. doi: 10.1111/his.14830. PMID:36254632.
  71. Suzuki T, Masugi Y, Inoue Y, Hamada T, Tanaka M, Takamatsu M, Arita J, Kato T, Kawaguchi Y, Kunita A, Nakai Y, Nakano Y, Ono Y, Sasahira N, Takeda T, Tateishi K, Uemura S, Koike K, Ushiku T, Takeuchi K, Sakamoto M, Hasegawa K, Kitago M, Takahashi Y, Fujishiro M; GTK Pancreatic Cancer Study Group in Japan. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. Cancer Sci. 2022-9;113(9):3097-3109. doi:10.1111/cas.15398. PMID:35567350.
  72. Takahashi K, Podyma-Inoue KA, Saito M, Sakakitani S, Sugauchi A, Iida K, Iwabuchi S, Koinuma D, Kurioka K, Konishi T, Tanaka S, Kaida A, Miura M, Hashimoto S, Okada M, Uchihashi T, Miyazono K, Watabe T. TGF-β generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via keratin-associated protein 2-3. Cell Reports. 2022-9;40:111411. doi:10.1016/j.celrep.2022.111411. PMID:36170816.
  73. Takami H, Mukasa A, Takayanagi S, Koike T, Matsuura R, Ikemura M, Ushiku T, Yoshikawa G, Shibahara J, Tanaka S, Saito N. Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report. Brain Tumor Pathol. 2023-1;40(1):26-34. doi: 10.1007/s10014-022-00448-z. PMID:36572828.
  74. Tamura N, Sakaguchi Y, Furutani W, Matsui M, Nagao S, Sakuma N, Fukagawa K, Miura Y, Mizutani H, Ohki D, Kataoka Y, Saito I, Ono M, Minatsuki C, Tsuji Y, Ono S, Kodashima S, Abe H, Ushiku T, Yamamichi N, Koike K, Fujishiro M. Magnifying endoscopy with narrow-band imaging is useful in differentiating gastric cancer from matched adenoma in white light imaging. Sci Rep. 2022-5;12:8349. doi:10.1038/s41598-022-12315-0. PMID:35589745.
  75. Tanaka M, Kunita A, Yamagishi M, Katoh H, Ishikawa S, Yamamoto H, Abe J, Arita J, Hasegawa K, Shibata T, Ushiku T. KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression. Liver Int. 2022-10;42(10):2329-2340. doi: 10.1111/liv.15366. PMID:35833881.
  76. Tanaka M, Shinozaki-Ushiku A, Kunita A, Yasunaga Y, Akamatsu N, Hasegawa K, Ushiku T. High-grade transformation of pancreatic neuroendocrine tumor associated with TP53 mutations: A diagnostic pitfall mimicking neuroendocrine carcinoma. Pathol Int. 2022-8;72(8):411-418. doi: 10.1111/pin.13252. PMID:35698921.
  77. Teranishi Y, Okano A, Miyawaki S, Ohara K, Ishigami D, Hongo H, Dofuku S, Takami H, Mitsui J, Ikemura M, Komura D, Katoh H, Ushiku T, Ishikawa S, Shin M, Nakatomi H, Saito N. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index. Acta Neuropathol Commun. 2022-5;10:76. doi:10.1186/s40478-022-01377-w. PMID:35570314.
  78. Tian D, Shiiya H, Sato M, Shinozaki-Ushiku A, Yan HJ, Nakajima J. Pathological tumor long-to-short axis ratio as a prognostic factor in patients with thymic epithelial tumors. Thorac Cancer. 2022-9;13(17):2489-2498. doi:10.1111/1759-7714.14582. PMID:35861051.
  79. Tian D, Shiiya H, Takahashi M, Terasaki Y, Urushiyama H, Shinozaki-Ushiku A, Yan HJ, Sato M, Nakajima J. Noninvasive monitoring of allograft rejection in a rat lung transplant model: Application of machine learning-based 18F-fluorodeoxyglucose positron emission tomography radiomics. J Heart Lung Transplant. 2022-6;41(6):722-731. doi:10.1016/j.healun.2022.03.010. PMID:35430149.
  80. Tian D, Yan HJ, Shiiya H, Sato M, Shinozaki-Ushiku A, Nakajima J. Machine learning-based radiomic computed tomography phenotyping of thymic epithelial tumors: Predicting pathological and survival outcomes. J Thorac Cardiovasc Surg. 2023-2;165(2):502-516.e9. doi:10.1016/j.jtcvs.2022.05.046. PMID:36038386.
  81. Umekawa M, Saito K, Shinya Y, Hasegawa H, Kawashima M, Teranishi Y, Katano A, Ikemura M, Saito N. Stereotactic radiosurgery for recurrent pleomorphic adenoma of the lacrimal gland:a case report. Acta Neurochicr (Wien). 2023-1;165(1):221-224. doi:10.1007/s00701-022-05384-7. PMID:36241743.
  82. Urabe M, Matsusaka K, Ushiku T, Fukuyo M, Rahmutulla B, Yamashita H, Seto Y, Fukayama M, Kaneda A. Adenocarcinoma of the stomach and esophagogastric junction with low DNA methylation show poor prognoses. Gastric Cancer. 2023-1;26(1):95-107. doi: 10.1007/s10120-022-01344-3. PMID:36224483.
  83. Yamaguchi K, Horie C, Takane K, Ikenoue T, Nakagawa S, Isobe Y, Ota Y, Ushiku T, Tanaka M, Fujishiro J, Hoshino N, Arisue A, Nishizuka S, Aikou S, Shida D, Furukawa Y. Identification of odontogenic ameloblast associated as a novel target gene of the Wnt/β-catenin signaling pathway. Cancer Sci. 2023-3;114(3):948-960. doi: 10.1111/cas.15657. PMID:36382598.
  84. Yamazawa S, Ushiku T. Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype. Virchows Arch. 2022-5;480(5):1051-1062. doi:10.1007/s00428-022-03307-6. PMID:35243539.
  85. Yogi N, Usui G, Matsusaka K, Fukuyo M, Fujiki R, Seki M, Takano S, Abe H, Morikawa T, Ushiku T, Ohtsuka M, Kaneda A. Association of tumors having Epstein-Barr virus in surrounding lymphocytes with poor prognosis. Cancer Med. 2023-1;12(2):1122-1136. doi: 10.1002/cam4.4967. PMID:35726701.
  86. Yoshida D, Kamiya M, Kawashima S, Yoshioka T, Hino H, Abe A, Fujita K, Kojima R, Shinozaki-Ushiku A, Urano Y, Nakajima J. Rapid imaging of thymoma and thymic carcinoma with a fluorogenic probe targeting γ-glutamyltranspeptidase. Sci Rep. 2023-3;13(1):3757. doi: 10.1038/s41598-023-30753-2. PMID:36882498.

 

和文論文
  1. 大澤一太、池村雅子、阿部浩幸、牛久綾、入山高行、中西恵美、牛久哲男
    臍帯血管異常を伴った間葉系異形成胎盤の1例. 診断病理. 2022;39(4):266-272.

 

和文総説・著書
  1. 阿部浩幸、牛久哲男　腐食性食道炎. 非腫瘍性疾患病理アトラス 消化管 2023:52-53.
  2. 阿部浩幸、牛久哲男　食道胃接合部癌の特性. 臨床外科 2022;7:776-779.
  3. 阿部浩幸　腎生検検体の取扱い. 非腫瘍性疾患病理アトラス 腎 2022:136-139.
  4. 岩﨑晶子、牛久哲男　その他の感染症. 非腫瘍性疾患病理アトラス 消化管 2023:291-295．
  5. 岩﨑晶子、牛久哲男　リンパ球浸潤胃癌の病理学的特徴. 胃と腸 2022;57(7):913-921.
  6. 牛久綾　胸腺癌（1）扁平上皮癌. 腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍　第2版2022:40-45.
  7. 牛久綾　がんゲノム医療と病理学 糖尿病・内分泌代謝科 2022;55(1):80-89.
  8. 牛久哲男、岩﨑晶子、阿部浩幸、牛久綾　EBウイルス関連胃癌の病理像（通常病理，HE像・粘液形質など）. EBウイルス関連胃癌　改訂第2版 2022:14-20.
  9. 牛久哲男　がんの分子病理学(各論)胃がん. 病理と臨床 2022;40:204-211.
  10. 牛久哲男　胃の腸型腺腫と高分化管状腺癌. 病理と臨床 2022;40(10):1030-1034.
  11. 牛久哲男　高悪性度胃癌の分子病理学的特徴. 胃と腸 2022;57(4):434-439.
  12. 牛久哲男　focally enhanced gastritis. 胃と腸 2022;57(5):736.
  13. 牛久哲男　総論「小腸」非腫瘍性疾患病理アトラス 消化管 2023:15-19.
  14. 牛久哲男　Inflammatory bowel diseaseの上部消化管病変. 非腫瘍性疾患病理アトラス 消化管 2023:195-198.
  15. 鈴木理樹(分担執筆)　腫瘍様病変 その他. 腫瘍病理鑑別診断アトラス 肺癌第2版 2022:256-262.
  16. 六反啓文、牛久哲男　剥離性食道炎. 非腫瘍性疾患病理アトラス 消化管 2023:50-51.

 

学会発表

第111回日本病理学会総会 2022年4月14日～16日 神戸
[コアシンポジウム]

  1. 牛久哲男. 症例から学び、最先端に触れ、病理医の力を発揮する腫瘍病理学研究.
[ワークショップ]
  1. 牛久綾. がんゲノム医療において病理医が果たすべき役割.
[口演]
  1. 朝比奈祐一、日向宗利、相原一、小野寺宏、牛久哲男. 組織透明化技術を用いた食道癌ESD 検体の三次元的評価.
  2. 阿部浩幸、黒瀬優介、原田達也、深山正久、牛久哲男. 大腸生検病理画像の腫瘍検出におけるmultistage semantic segmentation 法の有用性.
  3. 鈴木理樹、笠島理加、横瀬智之、山口類、古川洋一、宮野悟、井元清哉、牛久綾、牛久哲男、宮城洋平. 高悪性度胎児型肺腺癌におけるKMT2C発現の解析.
  4. 田中麻理子、牛久綾、国田朱子、安永瑛一、赤松延久、長谷川潔、牛久哲男. TP53変異に伴い退形成性変化をきたした膵神経内分泌腫瘍：膵内分泌癌との鑑別ピットフォール.
  5. 早川美奈子、山澤翔、牛久哲男. Gastric inverted polyp 内に生じた滑膜肉腫の1例.
  6. 日向宗利. 病理AI実装研究会アノテーション法
  7. 山本周、牛久哲男. 家族性大腸腺腫症の同一家系内患者における胃病変の比較検討.
[示説]
  1. 名和純一、元井亨、堀口慎一郎、新井秀雄、櫻井奈津子、塩沢由美子、小川真澄、土岐典子、比島恒和. 急性骨髄性白血病に対する臍帯血移植後2 年で、ドナー由来のバーキットリンパ腫を発症した1例.
  2. 箱崎眞結、牛久哲男、橋本唯史、岩坪威. アルツハイマー病患者脳由来Aβ seed分子のin vivoにおけるAβ蓄積誘発効果の検討.

 

第21回東京大学生命科学シンポジウム 2022年6月18日 オンライン
[示説]

  1. 近藤篤史、牛久綾、六反啓文、国田朱子、池村雅子、牛久哲男. EBウイルスによるHit-and-Run型の胃発癌機構の実証.

 

第94回日本病理学会関東支部学術集会 2022年7月2日 オンライン　
[口演]

  1. 名和純一、日向宗利、田中麻理子、池村雅子、秋山佑子、久住藍、永井幸司郎、 佐藤伸一、牛久哲男. 組織学的に扁平上皮癌との鑑別が困難であったhypertrophic lichen planus様の皮膚irAEの一例.

 

第81回 日本癌学会学術総会 2022年9月29日～10月1日 横浜
[講演]

  1. 鯉沼代造、田村佑介、森川真大、堤修一、田邉諒、宮園浩平. トリプルネガティブ乳がん細胞におけるPolyI:CによるTGF-βシグナル抑制を介したパイロトーシス誘導及び細胞増殖抑制作用.
[シンポジウム]
  1. 井上カタジナアンナ、高橋和樹、須河内昭成、飯田渓太、岩淵禎弘、鯉沼代造、栗岡恭子、小西徹、田中晋、戒田篤志、三浦雅彦、橋本真一、岡田眞里子、内橋 俊大、宮園浩平、渡部徹郎. TGF-β enhances metastasis of oral cancer via generation of a population of cancer cells in G1 phase with high motility.
[英語口演および示説]
  1. 荻窪一貴、西田純、高橋恵生、森川真大、江幡正悟、鯉沼代造、宮園浩平. Identification of the mechanisms of malignant progression of triple-negative breast cancer via epigenetic changes.
[口演]
  1. Tatsunori Suzuki, Yohei Masugi, Tsuyoshi Hamada, Mariko Tanaka, Manabu Takamatsu, Akiko Kunita, Keisuke Tateishi, Kazuhiko Koike, Tetsuo Ushiku, Michiie Sakamoto, Kengo Takeuchi, Minoru Kitago, Mitsuhiro Fujishiro. Droplet digital PCR for KRAS mutations in pancreatic cancer: An analysis of clinical samples in a multicenter cohort.
  2. 宮國昂介、西田純、荻窪一貴、鯉沼代造、江幡正悟、宮園浩平. 腎細胞がんにおける脳転移の分子メカニズム解析.
[示説]
  1. 牛久綾、国田朱子、牛久哲男. 胃癌およびその他の消化管癌におけるマイクロサテライト不安定検査の妥当性の比較.
  2. 国田朱子、牛久綾、牛久哲男. RNAパネル検査に適した病理組織検体の取り扱い方法の最適化.
  3. 笠島理加、鈴木理樹、清水英悟、玉田嘉紀、新井田厚司、廣島幸彦、片山琴絵、山口類、山口貴世志、古川洋一、宮野悟、井元清哉、横瀬智之、宮城洋平. 遺伝子ネットワーク解析による高悪性度胎児性肺腺癌のパスウェイ予測・検討.

 

第96回日本病理学会関東支部学術集会 2022年10月15日 オンライン
[口演]

  1. 安永瑛一、池村雅子、名和純一、高見浩数、高柳俊作、田中將太、牛久哲男. 側脳室に発生し、経過中一貫して松果体病変を認めなかったKBTBD4変異陽性神経上皮腫瘍の一剖検例.

 

第61回日本臨床細胞学会秋季大会 2022年11月5日～6日 仙台
[示説]

  1. 板倉祐里、瀬田章、日向宗利、鈴木理樹. EUS-FNAにて診断に苦慮した膵臓退形成癌リンパ節転移の一例.
  2. 明賀伊織、瀬田章、竹内裕子、田中麻理子. 頭蓋底原発脊索腫の乳腺転移の一例.

 

第68回日本病理学会秋期特別総会 2022年11月17日～18日 盛岡
[示説]

  1. 近藤篤史、田中麻理子、大澤一太、牛久綾、国田朱子、安永瑛一、赤松延久、小峯弓子、鈴木伸三、藤城光弘、長谷川潔、牛久哲男. TP53変異付加により悪性度が高まったと考えられる膵神経内分泌腫瘍の進展過程をとらえた剖検例.

 

第41回日本認知症学会学術集会 2022年11月25日～27日 東京
[示説]

  1. 岸野祐也、松川浩二、松本大成、宮崎良太、若林朋子、野中隆、 亀谷富由樹、長谷川成人、橋本唯史、岩坪威. Casein kinase 1 δ/εがFUSの神経毒性に与える影響に関する検討.

 

日本消化管学会 2023年2月3日～5日 東京
[口演]

  1. 阿部浩幸. 消化管生検病理診断におけるAIの活用―成果と課題.

 

角膜カンファレンス2023  2023年2月9日～11日 横浜
[示説]

  1. 松浦智之、竹溪友佳子、朝比奈祐一、岩崎晶子、小野喬、北本昴大、豊野哲也、相原一、宮井尊史. 慢性眼ＧＶＨＤの石灰角膜変性に深部層状角膜移植術を行った１例.

 

第42回日本画像医学会 2023年2月17日～18日 東京
[シンポジウム]

  1. 池村雅子. 脳の海綿状血管奇形をめぐって：病理.

 

第95回日本胃癌学会総会 2023年2月23日～25日 札幌
[プレナリーセッション]

  1. 牛久哲男. ゲノム医療の基礎と実際.
[イブニングセミナー]
  1. 牛久哲男. 知っておきたい！胃がんBiomarkerの基礎知識 ～Her2から2まで～.

 

第97回日本病理学会関東支部学術集会 2023年3月4日 東京
[口演]

  1. 山本周、田中麻理子、辻陽介、吉村俊太郎、谷島翔、牛久哲男. 胃壁など腹腔内に多発したCalcifying fibrous tumorの一例.

 

第20回日本臨床腫瘍学会学術集会 2023年3月16日～18日 福岡
[シンポジウム]

  1. Tetsuo Ushiku. PD-L1 Testing in Gastric Cancer.
講演会・セミナー等
  1. 牛久哲男. 胃癌のHER2病理診断を考える 胃癌HER2テストのすべて. 2022年5月17日
  2. 牛久哲男. 症例を通して学ぶ胃病理学の基礎と臨床. 九州大学特別講義 2022年6月9日
  3. 牛久綾. がん遺伝子パネル検査－レポートの見方と結果の解釈. 第8回分子病理専門医講習会 2022年7月24日 東京
  4. 牛久綾. がん遺伝子パネル検査－レポートの見方と結果の解釈. 第9回分子病理専門医講習会 2022年8月6日 東京
  5. 牛久哲男. 胃癌HER2テストのすべて. HER2検査を考えるWebセミナー 2022年8月24日
  6. 牛久哲男. 胃癌HER2テストのすべて. HER2陽性診療の最前線 2022年9月1日
  7. 牛久哲男. ゲノム時代における胃癌の分子サブタイプ分類最前線. Gastric Cancer Web Seminar 2022年9月20日
  8. 牛久哲男. 胃癌HER2テストのすべて Cancer Supportive Care Web Seminar 2022年9月21日
  9. 牛久綾.「がん遺伝子パネル検査のレポートとエキスパートパネル」. 第2回分子病理Up to date講習会 2022年10月8日
  10. 牛久哲男. 胃癌HER2テストのすべて. 消化器がんのトータルケア 2022年10月12日
  11. 牛久哲男. HER2テストのすべて～胃癌から大腸癌まで～. Gastrointestinal cancer Web Seminar 2022年12月1日
  12. 牛久哲男. 胃癌HER2テストのすべて. 消化器外科Step Uo Seminar 2023年2月3日